Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Spinocerebellar ataxia 1 - (AD) | 13.1 | | | | * Spinocerebellar ataxia 1 - SCA1 | | * Olivopontocerebellar atrophy I - OPCA1 |
|
Spinocerebellar ataxia 2 - (AD) | 13.2 | | | | * Spinocerebellar ataxia 2 - SCA2 | | * Olivopontocerebellar atrophy II - OPCA | | * Amyotrophic lateral sclerosis 13 - ALS13 |
|
Spinocerebellar ataxia 3 (Machado-Joseph disease) - (AD) | 13.3 | | | | * Machado-Joseph disease - MJD | | * Spinocerebellar ataxia 3 - SCA3 |
|
Spinocerebellar ataxia 4 - (AD) | 13.4 | | | | * Spinocerebellar ataxia 4 - SCA4 |
|
Spinocerebellar ataxia 5 - (AD) | 13.5 | | | Spectrin, Beta, Nonerythrocytic, 2
|
|
| | * Spinocerebellar ataxia 5 - SCA5 | | * Spinocerebellar ataxia, autosomal recessive 14 - SCAR14 |
|
Spinocerebellar ataxia 6 - (AD) | 13.6 | | | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
| | * Spinocerebellar ataxia 6 - SCA6 | | * Cerebellar ataxia, paroxymal, acetazolamide-responsive - CAPA | | * Cerebellar ataxia, pure - CACNA1A | | * Acetazolamide-responsive hereditary paroxymal cerebellar ataxia - APCA | | * Episodic ataxia, type 2 - EA2 |
|
Spinal cerebellarataxia 7 (olivopontocerebellar atrophy III) - (AD) | 13.7 | | | | * Spinocerebellar ataxia 7 - SCA7 | | * Olivopontocerebellar atrophy III - OPCA3 |
|
Spinocerebellar ataxia 8 - (AD) | 13.8 | | | | * Spinocerebellar ataxia 8 - SCA8 |
|
Spinocerebellar ataxia 10 - (AD) | 13.9 | | | | * Spinocerebellar ataxia 10 - SCA10 |
|
Spinocerebellar ataxia 11 - (AD) | 13.10 | | | | * Spinocerebellar ataxia 11 - SCA11 |
|
Spinocerebellar ataxia 12 - (AD) | 13.11 | | | Protein phosphatase 2 regulatory subunit B, beta isoform
|
|
| | * Spinocerebellar ataxia 12 - SCA12 |
|
Spinocerebellar ataxia 13 - (AD) | 13.12 | | | Potassium voltage-gated channel, Shaw-related subfamily, member 3
|
|
| | * Spinocerebellar ataxia 13 - SCA13 |
|
Spinocerebellar ataxia 14 - (AD) | 13.13 | | | | * Spinocerebellar ataxia 14 - SCA14 |
|
Spinocerebellar ataxia 15 - (AD) | 13.14 | | | Inositol 1,4,5-triphosphate receptor type 1
|
|
| | * Spinocerebellar ataxia 15 - SCA15 |
|
Spinocerebellar ataxia 17 (Huntington disease-like) - (AD) | 13.15 | | | | * Spinocerebellar ataxia 17 - SCA17 |
|
Spinocerebellar ataxia 18 - (AD) | 13.16 | | | Interferon-related developmental regulator 1
|
|
| | * Spinocerebellar ataxia 18 - SCA18 |
|
Spinocerebellar ataxia 19 - (AD) | 13.17 | | | Potassium voltage-gated channel, Shal-related subfamily, member 3
|
|
| | * Spinocerebellar ataxia 19 - SCA19 | | * Brugada syndrome 9 - BRGDA9 |
|
Spinocerebellar ataxia 20 - (AD) | 13.18 | | | | * Spinocerebellar ataxia 20 - SCA20 |
|
Spinocerebellar ataxia 21 - (AD) | 13.19 | | | Transmembrane protein 240
|
|
| | * Spinocerebellar ataxia 19 - SCA21 |
|
Spinocerebellar ataxia 22 - (AD) | 13.20 | | | | * Spinocerebellar ataxia 21 - SCA22 |
|
Spinocerebellar ataxia 23 - ( AD) | 13.21 | | | | * Spinocerebellar ataxia 23 - SCA23 |
|
Spinocerebellar ataxia 25 - (AD) | 13.22 | | | | * Spinocerebellar ataxia 25 - SCA25 |
|
Spinocerebellar ataxia 26 - (AD) | 13.23 | | | Eukaryotic translation elongation factor 2
|
|
| | * Spinocerebellar ataxia 26 - SCA26 |
|
Spinocerebellar ataxia 27A - (AD) | 13.24 | | | Fibroblast growth factor 14
|
|
| | * Spinocerebellar ataxia 27A - SCA27 | | * Spinocerebellar ataxia 27B, late onset - SCA27 |
|
Spinocerebellar ataxia 27B, late onset - (AD) | 13.25 | | | Fibroblast growth factor 14
|
|
| | * Spinocerebellar ataxia 27A - SCA27 | | * Spinocerebellar ataxia 27B, late onset - SCA27 |
|
Spinocerebellar ataxia 28 - (AD) | 13.26 | | | AFG3 ATPase family gene 3-like 2 (S. cerevisiae) 1(M)
|
|
| | * Spinocerebellar ataxia 28 - SCA28 | | * Spastic ataxia 5 autosomal recessive - SPAX5 |
|
Spinocerebellar ataxia 29, congenital nonprogressive - (AD) | 13.27 | | | | * Cerebellar ataxia, congenital, nonprogressive, autosomal dominant - SCA29 |
|
Spinocerebellar ataxia 30 - (AD) | 13.28 | | | | * Spinocerebellar ataxia 30 - SCA30 |
|
Spinocerebellar ataxia 31 - (AD) | 13.29 | | | Brain expressed, associated with Nedd42
|
| | Thymidine kinase 2, mitochondrial(M)
|
|
| | * spinocerebellar ataxia-31 - SCA31 | | * Mitochondrial dna depletion syndrome, myopathic form - MTDPS3 | | * Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 3 - PEOB3 |
|
Spinocerebellar ataxia 32 (with azoospermia) - (AD) | 13.30 | | | | * Spinocerebellar ataxia 32 - SCA32 |
|
Spinocerebellar ataxia 34 - (AD) | 13.31 | | | ELOVL fatty acid elongase 4
|
|
| | * Spinocerebellar ataxia 34 - SCA34 |
|
Spinocerebellar ataxia 35 - (AD) | 13.32 | | | | * Spinocerebellar ataxia 35 - SCA35 |
|
Spinocerebellar ataxia 36 - (AD) | 13.33 | | | | * Spinocerebellar ataxia 31 - SCA36 |
|
Spinocerebellar ataxia 37 - (AD) | 13.34 | | | | * Spinocerebellar ataxia 37 - SCA37 |
|
Spinocerebellar ataxia 38 - (AD) | 13.35 | | | ELOVL fatty acid elongase 5
|
|
| | * Spinocerebellar ataxia 38 - SCA38 |
|
Spinocerebellar ataxia 40 - (AD) | 13.36 | | | Coiled-coil domain containing 88C
|
|
| | * Spinocerebellar ataxia 40 - SCA40 |
|
Spinocerebellar ataxia 41 - (AD) | 13.37 | | | Transient receptor potential cation channel subfamily C member 3
|
|
| | * Spinocerebellar ataxia 41 - SCA41 |
|
Spinocerebellar ataxia 42 - (AD) | 13.38 | | | calcium voltage-gated channel subunit alpha1 G
|
|
| | * Spinocerebellar ataxia 42 - SCA42 | | * Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits - SCA42ND |
|
Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits - (AD) | 13.39 | | | calcium voltage-gated channel subunit alpha1 G
|
|
| | * Spinocerebellar ataxia 42 - SCA42 | | * Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits - SCA42ND |
|
Spinocerebellar Ataxia, type 43 - (AD) | 13.40 | | | Membrane metallo-endopeptidase
|
|
| | * Charcot-Marie-Tooth neuropathy Type 2T - CMT2T | | * Spinocerebellar Ataxia, type 43 - SCA43 |
|
Spinocerebellar ataxia 44 - (AD) | 13.41 | | | Glutamate receptor metabotropic, 1
|
|
| | * Spinocerebellar ataxia 44 - SCA44 | | * Spinocerebellar ataxia, autosomal recessive 13 - SCAR13 |
|
Spinocerebellar ataxia 45 - (AD) | 13.42 | | | Fat tumor suppressor, Drosophila, Homologh of, 2
|
|
| | * Spinocerebellar ataxia 45 - SCA45 |
|
Spinocerebellar ataxia 46 - (AD) | 13.43 | | | Phospholipase D family, member 3
|
|
| | * Spinocerebellar ataxia 46 - SCA46 |
|
Spinocerebellar ataxia 47 - (AD) | 13.44 | | | Pumilio, Drosophila, Homologh of, 1
|
|
| | * Spinocerebellar ataxia 47 - SCA47 |
|
Spinocerebellar ataxia 48 - (AD) | 13.45 | | | STIP1 homology and U-box containing protein 1
|
|
| | * Spinocerebellar ataxia, autosomal recessive 16 - SCAR16 | | * Spinocerebellar ataxia 48 - SCA48 |
|
Spinocerebellar ataxia 49 - (AD) | 13.46 | | | Sterile Alpha Motif Domain-Containing Protein 9-Like
|
|
| | * Spinocerebellar ataxia 49 - SCA49 | | * Ataxia-pancytopenia syndrome - ATXPC |
|
Spinocerebellar ataxia 50 - (AD) | 13.47 | | | Pentraxin I, neuronal, NP1
|
|
| | * Spinocerebellar ataxia 50 - SCA50 |
|
Episodic ataxia type-2 ,and familial hemiplegic migraine - (AD) | 13.48 | | | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
| | * Spinocerebellar ataxia 6 - SCA6 | | * Cerebellar ataxia, paroxymal, acetazolamide-responsive - CAPA | | * Cerebellar ataxia, pure - CACNA1A | | * Acetazolamide-responsive hereditary paroxymal cerebellar ataxia - APCA | | * Episodic ataxia, type 2 - EA2 |
|
Episodic ataxia type-3 - (AD) | 13.49 | | | | * episodic ataxia type-3 - EA3 |
|
Episodic ataxia type-5 - (AD) | 13.50 | | | Calcium channel, voltage-dependent, beta 4 subunit
|
|
| | * episodic ataxia type 5, included - EA5 |
|
Episodic ataxia type-6 - (AD) | 13.51 | | | EAAT1 (excitatory amino acid transporter type 1)
|
|
| | * episodic ataxia type 6 - EA6 |
|
Episodic ataxia type-7 - (AD) | 13.52 | | | | * episodic ataxia type-7 - EA7 |
|
Episodic ataxia type-9 - (AD) | 13.53 | | | Sodium voltage-gated channel, alpha subunit 2; SCN2A
|
|
| | * Episodic ataxia type-9 - EA9 |
|
Acetazolamide responsive hereditary paroxysmal cerebellar ataxia - (AD) | 13.54 | | | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
| | * Spinocerebellar ataxia 6 - SCA6 | | * Cerebellar ataxia, paroxymal, acetazolamide-responsive - CAPA | | * Cerebellar ataxia, pure - CACNA1A | | * Acetazolamide-responsive hereditary paroxymal cerebellar ataxia - APCA | | * Episodic ataxia, type 2 - EA2 |
|
Neurological impairment - (AD) | 13.55 | | | Translocase of Outer Mitochondrial Membrane 70
|
|
| | * Neurological impairment |
|
Ataxia-pancytopenia syndrome - (AD) | 13.56 | | | Sterile Alpha Motif Domain-Containing Protein 9-Like
|
|
| | * Spinocerebellar ataxia 49 - SCA49 | | * Ataxia-pancytopenia syndrome - ATXPC |
|
Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
Friedreich ataxia 1 - (AR) | 13.57 | | | | * Friedreich ataxia - FRDA | | * Friedreich ataxia with retained reflexes - FARR |
|
Friedreich ataxia 2 - (AR) | 13.58 | | | | * friedreich ataxia 2 - FRDA2 |
|
Friedreich ataxia with selective vitamin E deficiency - (AR) | 13.59 | | | Tocopherol (alpha) transfer protein (ataxia (Friedreich-like) with vitamin E deficiency)
|
|
| | * Ataxia, Friedreich-like, with selective vitamin E deficiency - AVED | | * Ataxia with isolated vitamin E deficiency - TTPA |
|
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type) - (AR) | 13.60 | | | | * Spinocerebellar ataxia, infantile-onset, with sensory neuropathy - IOSCA | | * Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal - PEO3A |
|
Early onset ataxia with oculomotor apraxia and hypoalbunemia - (AR) | 13.61 | | | | * Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia - EAOH |
|
Autosomal recessive spinocerebellar ataxia, 2 - (AR) | 13.62 | | | Mitochondrial processing peptidase-alpha, KIAA0123
|
|
| | * Autosomal recessive spinocerebellar ataxia, 2 - SCAR2 |
|
Autosomal recessive spinocerebellar ataxia, 3 - (AR) | 13.63 | | | | * Spinocerebellar ataxia, autosomal recessive 3 - SCAR3 |
|
Autosomal recessive spinocerebellar ataxia, 4 - (AR) | 13.64 | | | Vacuolar protein sorting 37, Yeast, homolg of, A
|
|
| | * Spinocerebellar ataxia, autosomal recessive 4 - SCAR4 |
|
Galloway-Mowat syndrome 1 Formerly Autosomal recessive spinocerebellar ataxia, 5 - (AR) | 13.65 | | | WD Repeat-Containing Protein 73
|
|
| | * Galloway-Mowat syndrome 1 - GAMOS1 |
|
Autosomal recessive spinocerebellar ataxia, 6 - (AR) | 13.66 | | | | * Spinocerebellar ataxia, autosomal recessive 6 - SCAR6 |
|
Autosomal recessive spinocerebellar ataxia, 7 - (AR) | 13.67 | | | | * Spinocerebellar ataxia, autosomal recessive 7 - SCAR7 |
|
Autosomal recessive spinocerebellar ataxia, 8 - (AR) | 13.68 | | | Spectrin repeat containing, nuclear envelope 1 (nesprin 1)
|
|
| | * Dilated cardiomyopathy related to nesprin-1 | | * Spinocerebellar ataxia, autosomal recessive 8 - SCAR8 | | * Emery-dreifuss muscular dystrophy 4 - EDMD4 | | * Arthrogryposis multiplex congenita with nesprin-1 defect - AMCM |
|
Autosomal recessive spinocerebellar ataxia, 9 (with ubiquinone deficiency) - (AR) | 13.69 | | | | * spinocerebellar ataxia, autosomal recessive 9 - SCAR9 | | * Autosomal recessive spinocerebellar ataxia, 9 with ubiquinone deficiency - SCAR9 |
|
Spinocerebellar ataxia, autosomal recessive 10 - (AR) | 13.70 | | | | * Spinocerebellar ataxia, autosomal recessive 10 - SCAR10 |
|
Spinocerebellar ataxia, autosomal recessive 11 - (AR) | 13.71 | | | | * Spinocerebellar ataxia, autosomal recessive 11 - SCAR11 |
|
Spinocerebellar ataxia, autosomal recessive 12 - (AR) | 13.72 | | | WW Domain-Containing Oxidoreductase(M)
|
|
| | * Spinocerebellar ataxia, autosomal recessive 12 - SCAR12 |
|
Spinocerebellar ataxia, autosomal recessive 13 - (AR) | 13.73 | | | Glutamate receptor metabotropic, 1
|
|
| | * Spinocerebellar ataxia 44 - SCA44 | | * Spinocerebellar ataxia, autosomal recessive 13 - SCAR13 |
|
Spinocerebellar ataxia, autosomal recessive 14 - (AR) | 13.74 | | | Spectrin, Beta, Nonerythrocytic, 2
|
|
| | * Spinocerebellar ataxia 5 - SCA5 | | * Spinocerebellar ataxia, autosomal recessive 14 - SCAR14 |
|
Spinocerebellar ataxia, autosomal recessive 15 - (AR) | 13.75 | | | RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein
|
|
| | * Spinocerebellar ataxia, autosomal recessive 15 - SCAR15 |
|
Spinocerebellar ataxia, autosomal recessive 16 - (AR) | 13.76 | | | STIP1 homology and U-box containing protein 1
|
|
| | * Spinocerebellar ataxia, autosomal recessive 16 - SCAR16 | | * Spinocerebellar ataxia 48 - SCA48 |
|
Spinocerebellar ataxia, autosomal recessive 17 - (AR) | 13.77 | | | | * Spinocerebellar ataxia, autosomal recessive 17 - SCAR17 |
|
Spinocerebellar ataxia, autosomal recessive 18 - (AR) | 13.78 | | | Glutamate receptor, ionotropic, delta 2
|
|
| | * Spinocerebellar ataxia, autosomal recessive 18 - SCAR18 |
|
Spinocerebellar ataxia, autosomal recessive 19 (Lichtenstein-Knorr syndrome) - (AR) | 13.79 | | | Solute carrier family 9, member 1
|
|
| | * Spinocerebellar ataxia, autosomal recessive 19 - SCAR19 |
|
Spinocerebellar ataxia, autosomal recessive 20 - (AR) | 13.80 | | | | * Spinocerebellar ataxia, autosomal recessive 20 - SCAR20 |
|
Spinocerebellar ataxia, autosomal recessive 21 - (AR) | 13.81 | | | | * Spinocerebellar ataxia, autosomal recessive 21 - SCAR21 |
|
Spinocerebellar ataxia, autosomal recessive 22 - (AR) | 13.82 | | | Von Willebrand factor A domain Containing Protein 3B
|
|
| | * Spinocerebellar ataxia, autosomal recessive 22 - SCAR22 |
|
Spinocerebellar ataxia, autosomal recessive 23 - (AR) | 13.83 | | | Tyrosyl-DNA phosphodiesterase 2
|
|
| | * Spinocerebellar ataxia, autosomal recessive 23 - SCAR23 |
|
Spinocerebellar ataxia, autosomal recessive 24 - (AR) | 13.84 | | | Ubiquitin-Like Modifier Activating Enzyme 5
|
|
| | * Spinocerebellar ataxia, autosomal recessive 24 - SACR24 |
|
Spinocerebellar ataxia, autosomal recessive 25 - (AR) | 13.85 | | | Autophagy 5, S. Cerevisiae, Homolog of
|
|
| | * Spinocerebellar ataxia, autosomal recessive 25 - SCAR25 |
|
Spinocerebellar ataxia, autosomal recessive 26 - (AR) | 13.86 | | | W-Ray Repair, Complementing Defective, In Chinese Hamster, 1
|
|
| | * Spinocerebellar ataxia, autosomal recessive 26 - SCAR26 |
|
Spinocerebellar ataxia, autosomal recessive 27 - (AR) | 13.87 | | | Ganglioside induced differentiation associated protein 2
|
|
| | * Spinocerebellar ataxia, autosomal recessive 27 - SACR27 |
|
Spinocerebellar ataxia, autosomal recessive 28 - (AR) | 13.88 | | | tRNA-histidine guanyltransferase 1-like protein
|
|
| | * Spinocerebellar ataxia, autosomal recessive 28 - SCAR28 |
|
Spinocerebellar ataxia, autosomal recessive 29 - (AR) | 13.89 | | | VPS41 Subunit of Hops Complex
|
|
| | * Spinocerebellar ataxia - SCAR29 |
|
Spinocerebellar ataxia, autosomal recessive 30 - (AR) | 13.90 | | | Pitrilysin metallopeptidase 1
|
|
| | * Spinocerebellar ataxia, autosomal recessive 30 - SCAR30 |
|
Spinocerebellar ataxia, autosomal recessive 31 - (AR) | 13.91 | | | | * Spinocerebellar ataxia - SCAR31 |
|
Spinocerebellar ataxia, autosomal recessive 32 - (AR) | 13.92 | | | | * Spinocerebellar ataxia, autosomal recessive 32 - SCAR32 |
|
Spinocerebellar ataxia, autosomal recessive 33 - (AR) | 13.93 | | | | * Spinocerebellar ataxia, autosomal recessive 33 - SCAR33 |
|
Spinocerebellar ataxia with axonal neuropathy - (AR) | 13.94 | | | Tyrosyl-DNA phosphodiesterase 1
|
|
| | * spinocerebellar ataxia, autosomal recessive, with axonal neuropathy - SCAN1 |
|
Spinocerebellar ataxia with axonal neuropathy type 2 - (AR) | 13.95 | | | | * Neuropathy, distal hereditary motor, with pyramidal features - ALS4 | | * Spinocerebellar ataxia, autosomal recessive 1 - SCAR1 | | * Spinocerebellar ataxia with axonal neuropathy type 2 - SCAN2 |
|
Spinocerebellar ataxia with axonal neuropathy type 3 - (AR) | 13.96 | | | Cytochrome C oxidase assembly factor 7
|
|
| | * Spinocerebellar ataxia with axonal neuropathy type 3 - SCAN3 |
|
Marinesco-Sjogren syndrome (cerebellar ataxia with cataract and myopathy) - (AR) | 13.97 | | | SIL1 homolog, endoplasmic reticulum chaperone
|
|
| | * Marinesco-Sjogren syndrome - MSS |
|
Sensory ataxic neuropathy, dysarthria and ophtalmoparesis - (AR) | 13.98 | | | Polymerase (DNA directed), gamma(M)
|
|
| | * Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis - SANDO | | * spinocerebellar ataxia with epilepsy, included - SCAE | | * Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal - PEOA1 | | * Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 - PEOB1 | | * Mitochondrial DNA depletion syndrome 4B (MNGIE type) - MTDPS4B | | * Mitochondrial DNA depletion syndrome 4A (Alpers type) - MTDPS4A |
|
Ataxia telangiectasia - (AR) | 13.99 | | | Ataxia telangiectasia mutated
|
|
| | * ataxia telangiectasia - AT |
|
Ataxia telangiectasia-like disorder 1 - (AR) | 13.100 | | | MRE11 meiotic recombination 11 homolog A
|
|
| | * ataxia telangiectasia-like disorder - ATLD |
|
Ataxia telangiectasia-like disorder 2 - (AR) | 13.101 | | | Proloferating cell nuclear antigen
|
|
| | * Ataxia telangiectasia-like disorder 2 - ATLD2 |
|
Spastic ataxia, Charlevoix-Saguenay type - (AR) | 13.102 | | | | * Autosomal recessive spastic ataxia of Charlevoix-Saguenay - ARSACS | | * Charcot-Marie-Tooth disease, axonal; related to SACS | | * Spastic ataxia, Charlevoix-Saguenay type - SACS | | * Spastic ataxia Charlevoix-Saguenay type - SPAX6 |
|
Peroxisome biogenesis disorder 9B (Refsum disease-1, adult) - (AR) | 13.103 | | | Phytanoyl-CoA 2-hydroxylase
|
|
| | * Refsum disease, adult - RD |
|
Refsum disease-2 (adult) - (AR) | 13.104 | | | Peroxisomal biogenesis factor 7
|
|
| | * Refsum disease, adult - RD |
|
Cerebellar ataxia and hypogonadotropic hypogonadism (Goedon Holmes syndrome) - (AR) | 13.105 | | | | * Cerebellar ataxia and hypogonadotropic hypogonadism (Goedon Holmes syndrome) - GDHS |
|
Myopathy, mitochondrial and cerebellar ataxia - (AR) | 13.106 | | | Misato homolog 1 (Drosophila)(M)
|
|
| | * Myopathy, mitochondrial and cerebellar ataxia - MMYAT |
|
Leukodystrophy hypomyelinating 23 with ataxia, deafness, liver dysfunction and dilated cardiomyopathy | 13.107 | | | | * Leukodystrophy hypomyelinating 23 with ataxia, deafness, liver dysfunction and dilated cardiomyopathy - HLD23 |
|
Cerebellar ataxia with neuropathy, hearing loss and intellectual disability - (XL) | 13.108 | | | Apoptosis-inducing factor, Mitochondria-associated 1(M)
|
|
| | * Neuropathy, axonal motor-sensory, with deafness and mental retardation - NAMSD | | * Charcot-Marie-Tooth disease, X-linked 4 (Cowchock syndrome) - COWCK | | * Charcot-Marie-Tooth disease with deafness and mental retardation - NAMSD | | * Combined Oxidative phosphorylation Deficiency 6 - COXPD6 | | * Cerebellar ataxia with neuropathy, hearing loss and intellectual disability |
|
Neurodevelopmental Syndrome with Hypotonia, Cerebellar Atrophy and Epilepsy - (AR) | 13.109 | | | Phosphatidylinositol Glycan Anchor Biosynthesis Class K Protein
|
|
| | * Neurodevelopmental Syndrome with Hypotonia, Cerebellar Atrophy and Epilepsy - NEDHCAS |
|
Coenzyme Q10 deficiency - (AR) | 13.110 | | | Coenzyme Q5 Methyltransferase(M)
|
|
| | * Coenzyme Q10 deficiency - COQ10D9 |
|